Patents Assigned to HZNP LIMITED
-
Patent number: 10058519Abstract: The field involves compositions useful for pain relief, including diclofenac solution and gel formulations, in particular methods of use thereof, articles of manufacture and kits that provide novel preclinical, clinical and other information to users.Type: GrantFiled: May 30, 2017Date of Patent: August 28, 2018Assignee: HZNP LimitedInventors: Jagat Singh, Joseph Zev Shainhouse, Bradley S. Galer, Robert Dominic King-Smith, Lisa Marie Grierson, Maria Burian, Jonathan Wilkin, Edward Kisak, John M. Newsam
-
Patent number: 9539335Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.Type: GrantFiled: April 6, 2016Date of Patent: January 10, 2017Assignee: HZNP LimitedInventors: Ed Kisak, Jagat Singh
-
Patent number: 9504699Abstract: The present invention refers to the treatment of a rheumatic disease and/or osteoarthritis by administering a delayed-release dosage form of a glucocorticoid to a subject in need thereof.Type: GrantFiled: December 8, 2014Date of Patent: November 29, 2016Assignee: HZNP LimitedInventor: Achim Schaeffler
-
Patent number: 9415029Abstract: The field involves compositions useful for pain relief, including diclofenac solution and gel formulations, in particular methods of use thereof, articles of manufacture and kits that provide novel preclinical, clinical and other information to users.Type: GrantFiled: October 26, 2015Date of Patent: August 16, 2016Assignee: HZNP LimitedInventors: Jagat Singh, Joseph Zev Shainhouse, Bradley S. Galer, Robert Dominic King-Smith, Lisa Marie Grierson, Maria Burian, Jonathan Wilkin, Edward Kisak, John M. Newsam
-
Patent number: 9375412Abstract: The field involves compositions useful for pain relief, including diclofenac solution and gel formulations, in particular methods of use thereof, articles of manufacture and kits that provide novel preclinical, clinical and other information to users.Type: GrantFiled: July 27, 2015Date of Patent: June 28, 2016Assignee: HZNP LimitedInventors: Jagat Singh, Joseph Zev Shainhouse, Bradley S. Galer, Robert Dominic King-Smith, Lisa Marie Grierson, Maria Burian, Jonathan Wilkin, Edward Kisak, John M. Newsam
-
Patent number: 9370501Abstract: The field involves compositions useful for pain relief, including diclofenac solution and gel formulations, in particular methods of use thereof, articles of manufacture and kits that provide novel preclinical, clinical and other information to users.Type: GrantFiled: July 21, 2015Date of Patent: June 21, 2016Assignee: HZNP LimitedInventors: Jagat Singh, Joseph Zev Shainhouse, Bradley S. Galer, Robert Dominic King-Smith, Lisa Marie Grierson, Maria Burian, Jonathan Wilkin, Edward Kisak, John M. Newsam
-
Patent number: 9339551Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.Type: GrantFiled: May 6, 2015Date of Patent: May 17, 2016Assignee: HZNP LimitedInventors: Ed Kisak, Jagat Singh
-
Patent number: 9339552Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.Type: GrantFiled: October 26, 2015Date of Patent: May 17, 2016Assignee: HZNP LimitedInventors: Ed Kisak, Jagat Singh
-
Patent number: 9220784Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.Type: GrantFiled: May 6, 2015Date of Patent: December 29, 2015Assignee: HZNP LIMITEDInventors: Ed Kisak, Jagat Singh
-
Patent number: 9168304Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.Type: GrantFiled: May 6, 2015Date of Patent: October 27, 2015Assignee: HZNP LIMITEDInventors: Ed Kisak, Jagat Singh
-
Patent number: 9168305Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.Type: GrantFiled: May 6, 2015Date of Patent: October 27, 2015Assignee: HZNP LIMITEDInventors: Ed Kisak, Jagat Singh
-
Patent number: 9132110Abstract: The field involves compositions useful for pain relief, including diclofenac solution and gel formulations, in particular methods of use thereof, articles of manufacture and kits that provide novel preclinical, clinical and other information to users.Type: GrantFiled: October 31, 2012Date of Patent: September 15, 2015Assignee: HZNP LIMITEDInventors: Jagat Singh, Joseph Zev Shainhouse, Bradley S. Galer, Robert Dominic King-Smith, Lisa Marie Grierson, Maria Burian, Jonathan Wilkin, Edward Kisak, John M. Newsam
-
Patent number: 9101591Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.Type: GrantFiled: January 14, 2015Date of Patent: August 11, 2015Assignee: HZNP LIMITEDInventors: Ed Kisak, Jagat Singh
-
Patent number: 9066913Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.Type: GrantFiled: September 25, 2014Date of Patent: June 30, 2015Assignee: HZNP LIMITEDInventors: Ed Kisak, Jagat Singh